Hem › Ateroskleros › Missouri › Kansas City
Kliniska studier för Ateroskleros i Kansas City, MO
4 studier för Ateroskleros söker deltagare vid platser i och runt Kansas City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekryterarFas 3
- Alliance for Multispecialty Research - Kansas City, Kansas City
- Kansas City Veterans Affairs Medical Center, Kansas City
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RekryterarFas 2/3
- Clinical Research Consultants, Kansas City
- Kansas City VA Medical Center, Kansas City
- DCI-Rockhill, Kansas City
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RekryterarFas 3
- Research Site, Kansas City
- Research Site, Kansas City
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
RekryterarFas 4
- Kansas City VA Medical Center, Kansas City, MO, Kansas City
Ateroskleros-studier i andra städer
- Boston, MA10 studier
- Houston, TX10 studier
- Washington, DC9 studier
- Hialeah, FL8 studier
- Arlington, VA8 studier
- Orlando, FL8 studier
- Memphis, TN7 studier
- Miami, FL7 studier
- Las Vegas, NV7 studier
- Durham, NC7 studier
- Dallas, TX7 studier
- San Diego, CA6 studier
Andra studier i Kansas City
- Bröstcancer34 studier
- Icke-småcellig lungcancer31 studier
- Hjärtsvikt25 studier
- Cancer (alla typer)21 studier
- Lungcancer19 studier
- Kolorektal cancer16 studier
- Metastaserande cancer15 studier
- Akut myeloid leukemi15 studier
- Prostatacancer14 studier
- Äggstockscancer11 studier
- Övervikt11 studier
- Typ 2-diabetes11 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.